JL

Jeffrey M. Leiden

Chair, Vertex Pharmaceuticals

Jeffrey M. Leiden is a chair at Vertex Pharmaceuticals. Their most recent Section 16 filing is from February 2026.

Known for
chair at Vertex Pharmaceuticals

Sign up

Get your curated digest

After email confirmation, you will receive a daily digest of the most relevant news that matter to your portfolio